Hedge Fund - Perceptive Advisors

Neurocrine Biosciences Inc (NBIX) 

Holding History Records
No. Filing Period Value % of Portfolio Number of Shares Avg. Quarterly Share Price
1 2025 - Q1 (2025-03-31) $11,065,530 0.39% 100,050 $126.68
2 2024 - Q4 (2024-12-31) $13,656,825 0.37% 100,050 $123.68
3 2024 - Q3 (2024-09-30) $24,452,910 0.51% 212,228 $137.09
4 2024 - Q2 (2024-06-30) $89,472,972 2.15% 649,909 $137.14
5 2024 - Q1 (2024-03-31) $110,944,089 1.94% 804,409 $136.57
6 2023 - Q4 (2023-12-31) $35,679,817 0.79% 270,794 $115.11
7 2023 - Q3 (2023-09-30) $17,914,725 0.59% 159,242 $105.30
8 2023 - Q2 (2023-06-30) $9,434,715 0.27% 100,050 $97.71
9 2023 - Q1 (2023-03-31) $10,127,061 0.29% 100,050 $104.06
10 2022 - Q4 (2022-12-31) $11,949,972 0.33% 100,050 $117.13
11 2022 - Q3 (2022-09-30) $10,626,000 0.3% 100,050 $101.46
12 2022 - Q2 (2022-06-30) $38,786,000 1.21% 397,888 $92.29
13 2022 - Q1 (2022-03-31) $37,091,000 0.74% 395,639 $84.75
14 2021 - Q4 (2021-12-31) $41,138,000 0.63% 483,007 $91.99
15 2021 - Q3 (2021-09-30) $46,325,000 0.67% 483,007 $94.46
16 2021 - Q2 (2021-06-30) $79,007,000 1.02% 811,832 $95.85
17 2021 - Q1 (2021-03-31) $91,593,000 1.15% 941,832 $104.86
18 2020 - Q4 (2020-12-31) $182,040,000 1.95% 1,899,215 $96.59
19 2020 - Q3 (2020-09-30) $148,924,000 2.17% 1,548,715 $115.68
20 2020 - Q2 (2020-06-30) $261,252,000 4.23% 2,141,410 $110.51
21 2020 - Q1 (2020-03-31) $265,126,000 6.9% 3,063,263 $97.87
22 2019 - Q4 (2019-12-31) $388,313,000 7.71% 3,612,554 $104.70
23 2019 - Q3 (2019-09-30) $365,837,000 9.85% 4,059,900 $93.43
24 2019 - Q2 (2019-06-30) $339,734,000 7.79% 4,023,862 $82.11
25 2019 - Q1 (2019-03-31) $331,138,000 9.34% 3,758,662 $83.58
26 2018 - Q4 (2018-12-31) $315,363,000 12% 4,608,554 $95.81
27 2018 - Q3 (2018-09-30) $587,363,000 15.7% 4,777,254 $113.46
28 2018 - Q2 (2018-06-30) $463,226,000 12.14% 4,715,250 $89.51
29 2018 - Q1 (2018-03-31) $394,912,000 11.06% 4,761,989 $84.45
30 2017 - Q4 (2017-12-31) $399,712,000 13.24% 5,151,589 $68.21
31 2017 - Q3 (2017-09-30) $293,629,000 11.21% 4,791,589 $52.77
32 2017 - Q2 (2017-06-30) $164,569,000 8.28% 3,577,589 $48.51
33 2017 - Q1 (2017-03-31) $145,771,000 8.3% 3,366,530 $42.84
34 2016 - Q4 (2016-12-31) $128,349,000 9.12% 3,316,523 $45.27
35 2016 - Q3 (2016-09-30) $125,398,000 8.09% 2,476,272 $49.80
36 2016 - Q2 (2016-06-30) $127,167,000 8.81% 2,797,967 $46.04
37 2016 - Q1 (2016-03-31) $107,614,000 9.43% 2,720,967 $39.68
38 2015 - Q4 (2015-12-31) $141,208,000 10.44% 2,496,167 $50.83
39 2015 - Q3 (2015-09-30) $117,101,000 9.36% 2,942,967 $48.33
40 2015 - Q2 (2015-06-30) $156,866,000 9.44% 3,284,467 $42.40
41 2015 - Q1 (2015-03-31) $148,566,000 11.54% 3,741,267 $35.77
42 2014 - Q4 (2014-12-31) $79,648,000 6.67% 3,565,267 $18.95
43 2014 - Q3 (2014-09-30) $71,538,000 7.75% 4,565,267 $14.95
44 2014 - Q2 (2014-06-30) $68,262,000 6.69% 4,599,867 $14.11
45 2014 - Q1 (2014-03-31) $74,372,000 7.81% 4,619,367 $17.10
46 2013 - Q4 (2013-12-31) $39,076,000 4.69% 4,183,737 $9.76
47 2013 - Q3 (2013-09-30) $48,344,000 3.92% 4,270,704 $13.75
48 2013 - Q2 (2013-06-30) $67,993,000 6.85% 5,081,717 $12.28
49 2013 - Q1 (2013-03-31) $53,492,000 6.42% 4,402,637 $10.18
50 2012 - Q4 (2012-12-31) $30,609,000 5.41% 4,092,137 $7.60
51 2012 - Q3 (2012-09-30) $29,296,000 6.67% 3,671,137 $7.64
52 2012 - Q1 (2012-03-31) $28,724,000 6.87% 3,604,037 $8.47

The displayed share prices are average quarterly stock market prices.